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Advancement in the knowledge ledge of pancreatic function, the discovery of ,
insulin and the modern treatment of diabetes are the result of exper imenta l 
studies of this disease. Further and no less important benefits can be 
expected from the continuance of these studies. In this paper problems 
now occupying experimental scientists Nvill be presented to the general 
practitioner, specially emphasizing the practical results so far obtained. 
Only an outline of the work being done can be niven. Metabolic dis-
turbances producing a simple transitory hyperglycaemia, such as those due 
to injection or secretion of adrenaline or other hormones and drugs, or 
stimulating of nerve centres, as occurs after puncturing the medulla, will 
not be considered. It will be understood there is a true diabetic condition 
only when there is permanent hyperglycemia together with severe meta-
bolic changes : fasting hyperglycaemia and glycosuria, a typical pro-
longed sugar tolerance curve, changes in the R.Q. hyperketonaemia and 
ketonuria, loss of weight, cachexia, etc. 
PANCREATIC DIABETES AND INSULIN 
Diabetes was produced experimentally for the fi rst time by von Mering 
and Minkowski in 1889, by total extirpation of the pancreas in the dog. 
This experiment proved that diabetes is due to pancreatic insufficiency. 
Diabetes is caused by the suppression of the internal secretion of the 
pancreas, as the following experiments have shown : 
(a) Pancreatic grafts prevent the onset of diabetes if performed at the 
same time as the removal of the organ ; and correct the diabetic altera-
tions, if the graft is made when diabetes has already developed. 
(b) Venous blood coming from the pancreas, produces hypoglycaemia. 
(c) Insulin, the hormone obtained from the pancreas, prevents the 
appearance of, or corrects, diabetes and permits pancreatectomized dogs 
to survive many years if they are adequately fed (Hedon, Chaikoff and 
Kaplan, 1927). 
Banting and Best's 1922 experimental studies led to the discovery of 
insulin ; increased knowledge of carbohydrate metabolism and diabetes, 
and gave the foundation for dietetic and insulin treatment of the disease. 
Insulin is secreted by the Langerhans islets of the pancreas. This is 
proved by 2 principal facts : 
1. Atrophy of the glandular acini, induced by ligature of the pancreatic 
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duct, does not produce diabetes as long as the islets remain in good 
condition (Szobolew). 
2. Severe lesions producing atrophy of the islets provoke a complete 
diabetic state, even when the acini are in good condition ; this selective 
suppression of ß cells of the islets can be obtained by means of anterior 
hypophyseal extract and alloxan ; also in certain conditions by thyroid 
feeding. 
Benign and malignant hyperplasia of the Langerhans islets, giving an 
excessive secretion of insulin, produce symptoms of hyperinsulinism. 
Hypoglycaemic crises, typical of this condition, can be suppressed by 
removal of the islet tumours or ample resection of the pancreas. Liver 
metastases of these tumours contain insulin. 
The liver is indispensable for the establishment of diabetes, whatever 
the diabetogenic factor, even after pancreatectomy. It is also necessary 
for the continuance of the diabetic condition, since 
hepatectomy is 
followed by a fall in the blood sugar from the high diabetic level to 
a fatal 
hypoglycaemia (Mann et al.). 
Between 1922 and 1930 it was commonly accepted that the 
pancreas 
was the only important factor in the pathogenesis of 
diabetes. The part 
played by the liver in the production of sugar and the regulation of the 
blood sugar level was demonstrated later, as also the 
importance of other 
endocrine glands. 
HYPOPHYSEAL AND METAHYPOPHYSEAL 
DIABETES 
The frequent existence of diabetes in acromegaly has 
been known for a 
long time. Atkinson states that 32.8% of cases of 
acromegaly reported 
in the literature up to 1938 had glycosuria or diabetes. 
The diabetogenic 
role of the anterior lobe of the hypophysis was first 
demonstrated in 1930 
in my Institute. Hypophysectomy increases 
sensitiveness to insulin 
(Houssay and Magenta, 1924 and 1929), due to 
removal of the pars 
distalis, commonly called the anterior lobe in 
mammals. This hyper 
sensitiveness can he corrected by injection of the 
anterior lobe extract 
(Houssay and Potick, 1929). 
Later, in 1930, Houssay and Biasotti showed that removal of the 
hypophysis or the pars distalis alone improves 
pancreatic diabetes in the 
dog and toad and phloridzin diabetes in the dog. 
In the toad, implanta-
tion of the pars distalis is followed by an increase 
in the severity of the 
diabetic symptoms to the level existing before 
hypophysectomy or even 
more. The diabetogenic activity of 
the 
hypophysis has thus been com-
pletelyThe -diabetogenic activity of the anterior 
lobe (pars distalis) of the 
hypophysis of mammals was demonstrated in 1932 
in 3 laboratories. 
*By Evans, Meyer, Simpson and Reichert in California ; 
by Bauman and 
New York and by 
Marine in 




Since then it has been a major subject of study in the Institute of Physiology 
of the Buenos Aires Faculty of Medicine. 
Hypophyseal diabetes must he distinguished from metahypophyseal 
diabetes. Hypophyseal diabetes is produced by the injection of anterior 
lobe extract and rapidly disappears on discontinuing the treatment for 
1 or 2 days. Though there is hyperglycaemia, the islets are not yet 
severely damaged and the pancreas secretes insulin (Houssay, 
Smyth, Riett, Houssay, 1944). Later the damage is more severe and 
insulin secretion is considerably reduced or even suppressed. The lesions 
observed consist in reduction of the granules. hydropic degeneration and 
pyknosis of the ß -cells. These alterations are reversible and they dis-
appear when the treatment is discontinued. Insulin secretion is also 
re-established. 
When the treatment with anterohypophyseal extract is more prolonged, 
the lesions are even more severe and become irreversible. The ß-cells 
disintegrate and disappear and the islets atrophy. When the injections 
are discontinued the animals do not recover, remaining with a permanent 
diabetes. I have called this condition metahypophyseal diabetes. It 
is a pancreatic diabetes due to insufficiency of the Langerhans islets, 
provoked by the anterohypophyseal extract, but not maintained by this 
extract. This permanent metahypophyseal diabetes was first demon-
strated in dogs with a subtotal pancreatectomy (Houssay, Biasotti and 
Rietti, 1932) and later in dogs with a whole pancreas (Young, 1937). 
Young's work on this form of diabetes is particularly important. Table I 
gives a summary of the principal differences between hypophyseal and 
metahypophyseal diabetes. 
TABLE I 
Hypophyseal Diabetes Metahypophyseal Diabetes 
Anterior lobe extract 
injections 
Damage to ß-cells 
Resistance to insulin 
Liver glycogen 
Course 
Necessary to maintain 
the condition, which dis-




High or normal 
Cure or onset of meta-
hypophyseal diabetes 
Unnecessary to maintain 
the condition, which per-
sists after discontinuing 
treatment. 
Irreversible 





*It decreases only when there is considerable hyperglycaemia (250 to 300 mg. per 100 cc. 
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The diabetogenic effect can be obtained with smaller doses of antero, 
hypophyseal extract when the pancreas is partially removed (Houssay 
Biasotti and Rietti, 1932-34). It is also more easily provoked by a second 
or third series of injections of anterohypophyseal extract that follows the 
previous one after a few days interval. Pancreatic resistance is dimin-
ished when the number of islets is reduced or the 
ß 
-cells are damaged. 
Two factors are responsible for the production of this diabetes : hyper-
glycaemia and damage to the islets. 
The role of hyperglycaemia can be demonstrated in several ways. 
Diabetes is not produced if the animals are kept fasting ; on the contrary. 
it is easily provoked when a diet rich in saccharose rose is given (Houssay and 
Biasotti). The diabetic state is preceded by an initial hyperglycaemia, 
extrapancreatic in origin, since it can be seen very plainly in the hypo-
physectomized pancreatectomized animal. This form of diabetes can 
be prevented or cured during the fi rst stages by means of hypoglycaemic 
agents such as insulin or phloridzin (Lukens and Dohan, 1942). 
The damaging effect of the anterohypophyseal extract has also been 
demonstrated. Hyperglycaemia maintained during 4 days by intra-
venous injection of glucose does not alter the islet cells nor does it dim-
inish insulin secretion in dogs. On the other hand severe lesions of the 
-cells together with complete or almost complete suppression of insulin 
secretion are observed when hyperglycaemia of a similar degree is pro-
duced by injection of anterohypophyseal extract (Houssay, Foglia, 
Smyth, Rietti and Houssay, 1941). This extract also produces fatty 
degeneration of the liver, and the acini and fine ducts of the pancreas, 
and other alterations. 
Hypophyseal diabetes, the condition existing while the anterohypophy-
seal treatment is maintained, commences by an extrapancreatic phase to 
which a progressive insufficiency of the islets is added, due apparently to 
the exhaustion of the cells in the effort to cope with the hyperglycaemia. 
Initial hyperglycaemia is due to the excess production of sugar by the liver 
and the diminished consumption of glucose brought about by the hypo-
physeal factor. The result is a hyperglycaemia with a low R.Q., excess 
fat catabolism and increased ketogenesis. A notable characteristic of 
hypophyseal diabetes is a marked increase in resistance to insulin. 
Metahypophyseal diabetes is a simple pancreatic diabetes due to 
progressive destruction of the Langerhans islets. Its course is similar to 
Sandmeyer's diabetes produced by subtotal pancreatectomY, but usually 
its severity increases more rapidly. 
ADRENAL DIABETOGENIC ACTIVITY 
The following are the more important facts in favour of the adrenals 
having a diabetogenic effect. 
Clinical Proceedings 
EXPERIMENTAL DIABETES 223 
(a) Adrenalectomy diminishes the severity of symptoms in pancreatic 
diabetes in cats, rats and toads (Long 
ß 
and Lukens, Houssay and BIASOTTI, 
Foglia and Rietti). 
(b) Diabetes is seen in certain cases of hyperinterrenalism, of Cushing's 
disease and the Achard-Thiers syndrome (diabetes in bearded women). 
Adrenal cortical extracts and hormones increase the severity of symp-
toms in animals with a pancreatic diabetes which has been attenuated by 
adrenalectomy or hypophysectomy (Long et al., Gaunt et al.). These 
substances also increase glycosuria in fasting phloridzinized rats (Kendall 
et al.). 
Ingle (1941) observed marked hyperglycaemia and glycosuria in 
normal rats fed with a diet rich in carbohydrate, when they were injected 
with large doses of 11-dehydro-17-hydroxycorticosterone during several 
days. Up to now permanent diabetes has not been obtained by this 
method, perhaps because the treatment has not been sufficiently prolonged 
or the rat is not suitable for this demonstration. Repeated injections of 
diethylstilbestrol also produce glycosuria even after removal of the 
hypophysis and adrenals (Ingle, 1944). Recent studies on this subject 
have been reviewed by Long (1942) and Houssay and Deulofeu (1943). 
TIIYROID AND METATHYROID DIABETES 
Thyroid administration does not produce diabetes in animals with an 
intact pancreas and in good general condition (Houssay and Brignone). 
Sometimes a transitory hyperglycaemia of not more than 149 mg. per 
100 cc. has been observed in the dog. The Langerhans islets become 
hypertrophied in many species. 
Reduction of the pancreatic tissue, by surgical removal of 6-7 or 7-8 
of its mass, sensitizes the animal to thyroid treatment and a permanent 
diabetic condition is produced after a few weeks of thyroid treatment 
and a permanent diabetic condition is produced after a few weeks of 
thyroid feeding (De Finis and Houssay, 1944). The blood sugar rises, 
glycosuria, ketonuria and other diabetic symptoms appear. The -cells 
of the islets show progressive alterations, the granules diminish, hydropic 
degeneration, pyknosis and cytolysis follow each other bringing about 
complete disappearance of the cells and atrophy of the islets. 
Discontinuance of the thyroid treatment during the first stages is 
followed by a rapid return to a normal blood sugar, disappearance of all 
diabetic symptoms and recovery of the ß -cells not already completely 
destroyed. A more prolonged thyroid treatment produces a severer 
destruction of the cells, in which case the damage to the islets is irreversible 
and on discontinuance of the treatment the animal does not recover, but 
remains permanently diabetic. This diabetes appears during the 
thyroid treatment and because it disappears on discontinuance of the 
treatment, it is called by us thyroid diABETES Among its symptoms are 
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noticeable polyuria, frequently marked ketonuria and a moderate increase 
in insulin resistance. The mechanism of its production is not yet 
sufficiently well known. Probably 2 factors concur to alter the islets : 
(a) Hyperglycaemia. 
(b) The toxic action of the thyroid. 
Hyperglycaemia is probably of extrapancreatic origin and gradually 
exhausts the islets, so that a pancreatic insufficiency is added. One of the 
first alterations to occur is a disturbance in the formation of liver glycogen 
froM sugar, which brings about a decrease in the store of hepatic glycogen. 
A toxic action of the thyroid is probably added to the damaging effect of 
hyperglycaemia, since it is well known that in hyperthyroidism pro-
gressive lesions are observed in several organs, notably in the liver and in 
the heart. 
The diabetes persisting after discontinuance of the thyroid treatment 
is called by us, metathyroid diabetes. It is a diabetic condition due to 
insufficiency of the Langerhans islets provoked, but not maintained, by 
thyroid treatment. We have obtained it in 19 dogs with a subtotal 
pancreatectomy ; it did not occur in controls which had undergone a 
similar operation, but were not treated with thyroid. Other controls were 
fed for I month powdered liver, kidney or muscle instead of thyroid, and 
did not develop diabetes. This diabetogenic effect of the thyroid was 
observed after removal of the sexual glands, the thyroid and the adrenal 
medulla 
The diabetogenic effects of the anterohypophysis and the thyroid 
usually reinforce each other, but the association has a severe toxic action. 
This compound treatment produced a permanent diabetes in 3 dogs each 
with an intact pancreas. By grafting the pancreatic glands of these animals 
into the circulation of a diabetic dog it was possible to demonstrate that 
they did not secrete insulin. 
The diabetogenic action of the thyroid is thus completely demonstrated 
but it is not as intense as that of alloxan or anterohypophyseal extract. 
Thyroid treatment can only produce diabetes in animals with a pancreas 
reduced by surgical removal of a great part of its mass, or already damaged 
by a previous treatment with anterohypophyseal extract or thyroid. It 
cannot do so in animals with an intact and healthy pancreas. 
In man, hyperthyroidism increases the severity of diabetes and the same 
occurs, nearly always, when a diabetic patient is given thyroid treatment. 
Therefore in man similar effects to those observed in other species can be 
seen : an excess of thyroid produces an extrapancreatic metabolic effect, 
which increases the severity of diabetes and diminishes the effect of insulin ; 
also it can further damage a pancreas with a previously reduced resistance. 
Hyperthyroidism is not more frequent in diabetics than in the general 
population. On the other hand diabetes is twice as frequent in hyper-
thyroids as in the general population (John, 1942). This also is in agree-
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ment with experimental results showing the thyroid has a definite though 
weak diabetogenic activity. 
Thyroid insufficiency does not improve experimental diabetes in the 
dog. In human diabetes sugar tolerance is somewhat improved, glyco-
suria diminishes and the dose of insulin necessary to control the condition 
is decreased. The improvement is not greater than that which can be 
obtained by diet and insulin treatment and certainly does not justify a 
thyroidectomy. This operation produces myxoedema, a condition far 
more troublesome than diabetes, and it is not a good therapeutic result 
to leave a patient with 2 diseases instead of 1. 
Hyperthyroidism in diabetics should be actively treated by iodine, 
thiouracil or subtotal thyroidectomy. The majority of the cases are 
considerably improved. 
ALI.OXAN DIABETES 
Shaw Dunn and his collaborators showed that alloxan injections produce 
necrosis of the Langerhans islets, with pyknosis and lysis of the ß -cells 
and subsequent atrophy of the islets, with conservation of the ß -cells. 
This has been demonstrated in rabbits (Shaw Dunn, 1943 ; Bailley and 
Bailey, 1943 ; Hughes, Ware and Young, 1943 ; Kennedy and Young, 
1944 ; Goldner and Gomori, 1944), rats (Gomori and Goldner, 1943 ; 
Thorogood, 1944), dogs (Carrasco-Formiguera, 1943 ; Goldner and 
Gomori, 1944), monkeys, etc. In man it has not been observed in cases 
injected with alloxan (Brunschwig et al., 1944 ; Joslin, 1944) probably 
because the dose given was too small, or because there was habituation. 
In my laboratory the action of alloxan has been studied by Orias, Brig-
none, Martinez, Sara and Di Pietro in rats, cats, dogs, rabbits, guinea pigs 
and toads. 
The effects of this drug are not limited to the islets. There is a triphasic 
effect on the blood sugar. After an initial hyperglycaemia of short dura-
tion, there is hypoglycaemia during several hours ; it can be sufficiently 
marked to be fatal. Later alloxan diabetes appears. Glucose adminis-
tration prevents death from hypoglycaemia and facilitates the appearance 
of a permanent diabetes. Mortality is very high during the first days, and 
there are necrotic lesions in the kidneys, liver, etc. Larger doses produce 
nervous symptoms. Renal and hepatic lesions rapidly disappear if the 
animal survives, but atrophy of the Langerhans islets is usually marked 
and irreversible, so the animals frequently remain with a permanent 
diabetes. According to the terminology so far employed, this condition 
should be called meta-alloxan diabetes, since it is a diabetes due to islet 
insufficiency provoked, but not maintained, by alloxan. 
Hypophyseal and thyroid diabetes are due to islet lesions produced by 
the conjoint effect of hyperglycaemia and the toxic action of the drug on 
the ß-cells Alloxan diabetes is due solely to a toxic action which is 
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intense and immediate ; the alloxan injected disappears from the circula-
tion in 5 minutes. For this reason treatment of the initial hyperglycaemia 
with insulin, phloridzin or fasting, does not prevent the appearance of 
alloxan diabetes (Goldner and Gomori, 1944). A single dose of alloxan 
is sufficient to produce degeneration of the islets. This contrasts with the 
need for repeated doses of anterohypophyseal extract or thyroid to obtain 
the same effect. There is also an "all or none" phenomenon ; a given 
dose either produces diabetes or has no apparent effect. 
This type of alloxan or meta-alloxan diabetes has been obtained so far 
in rabbits, dogs and rats. 
DIABETES DUE TO SUBTOTAL PANCREATECTOMY 
Subtotal pancreatectomy does n Dt produce diabetes in the dog if 1-7 to 
1-8 of the pancreas is left, provided that insulin treatment is given during 
the first week following operation and aseptic precautions are rigorously 
observed. When the amount of gland left is smaller, frequently a mild 
diabetes occurs. In some cases the blood sugar returns to normal and 
glycosuria ceases. The islets are in good condition or may show signs of 
hyperplasia. In other cases the initially mild diabetic condition (Sand-
meyer's diabetes) gradually increases in severity until the animal dies with 
all the symptoms of a diabetes due to total pancreatectomy. A mild 
diabetes is never stabilized ; either it regresses and disappears or pro-
gresses and becomes increasingly severe. 
Metahypophyseal and metathyroid diabetes are similar to Sandmeyer's 
diabetes, since they follow a progressive course, with increasing severity, 
though usually they are more marked in the initial phases. In these cases 
the damage to the /3-cells is not complete at the beginning, but increases 
with time. The cells become gradually altered and disappear one after 
the other. 
All forms of mild diabetes become worse with diets rich in carbo-
hydrates. A normal dog can be fed any amount of sugar without 
becoming diabetic ; but a dog with a subtotal pancreatectomy, having a 
normal blood sugar and no glycosuria, can be made diabetic by feeding it 
with sugar, as was shown by Allen (1013), a fact we have repeatedly 
confirmed. 
After removing 95% of the pancreas from a rat, the blood sugar remains 
normal for 2 or 3 months. After this lapse a diabetic condition appears 
which increases gradually in a way similar to Sandmeyer's diabetes in the 
dog, but less rapidly in spite of the marked hyperglycaemia and glycosuria. 
The prolonged prediabetic stage, with no glycosuria is very remarkable in 
this species. Foglia (1944) has made a systematic study of this type of 
diabetes. 
PHLORIDZIN DIABETES 
Phloridzin is a glucoside which, injected into animals, produces intense 
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glycosuria. The condition, called phloridzin diabetes, is complex and has 
to be examined in detail. There is never hyperglycaemia, and frequently 
the blood sugar is below normal Glycosuria is due to incapacity of the 
kidney tubules to reabsorb the sugar fi ltered through the glomerulus. 
When the injections are repeated the continuous loss of sugar produces 
metabolic disturbances similar to those seen in pancreatic diabetes. In 
phloridzin diabetes there is an excess production of sugar, which is not 
used by the organism but is lost. In chronic intoxications by phloridzin, 
ketogenesis increases, the R.Q. is low and there are many other symptoms 
of a severe metabolic disturbance similar to diabetes. Glucose injection 
is followed by a more prolonged hyperglycaemia than in normal animals 
and less glycogen is formed in the muscles. 
This diabetic condition produces lesions in several organs, amongst 
others, in the pancreas. On the fi fth day of phloridzin treatment the 
pancreas was found to secrete insulin normally in 2 dogs ; less than 
normally in 5 animals ; in I case there was no insulin secretion, as 
demonstrated by the method of grafting the gland into the circulation of a 
diabetic dog. Administration of glucose to phloridzinised animals is 
followed by an increase in the R.Q. and formation of muscle glycogen in 
greater amounts than in pancreatectomized dogs. These observations 
show that phloridzinised animals probably secrete a certain amount of 
insulin. 
GENERAL DISCUSSION 
Metahypophyseal, metathyroid and meta-alloxan diabetes show that the 
endocrine function of the pancreas is performed by the Langerhans islets, 
since the destruction of the islets produces diabetes just as when the whole 
pancreas is removed. In all these cases the pancreatic acini are micro-
scopically normal, but there are severe lesions in the ß-cells of the islets, 
which at first lose their granules, then undergo hydropic degeneration 
and finally disintegrate, with subsequent atrophy of the islets. In all 
cases of diabetes there is insufficiency of the endocrine part of the pancreas, 
which is incapable of secreting the amount of insulin required by the 
organism. Even when the condition is initiated by extrapancreatic factors, 
as occurs in hypophyseal diabetes, a few days later hyperglycaemia has 
begun and the internal secretion of the pancreas diminishes. 
The surgical reduction of the pancreatic mass (therefore of the number 
of islets) diminishes the latter's resistance to the diabetogenic action of 
sugar and of agents that conjointly with hyperglycaemia damage the 
pancreas (anterohypophysis, thyroid). The decrease in insular reserve 
facilitates the action of those substances which must be given repeatedly 
to be effective. Alloxan, on the other hand, has the same activity in the 
subtotally pancreatectomized dog as in the normal animal, and less in the 
subtotally pancreatectomized rat, than in normal ones ; it acts directly 
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when it reaches a sufficient concentration in the blood. 
Repeated or persistent hyperglycaemia is an important cause of damage 
to the islets, as is seen when sugar, anterohypophysis 
ß 
or thyroid are 
repeatedly given. In these cases hyperglycaemia is initially due to extra-
pancreatic factors but later the hyperglycaemia itself damages the islets. 
As an increase in blood sugar stimulates the /3-cells it is supposed that at 
first there is hypersecretion, then functional exhaustion followed by 
damage and final destruction. 
In hypophyseal diabetes 2 factors occur to damage the islets, hyper-
glycaemia and the toxic action of the anterohypophyseal extract. Hyper-
glycaemia is a necessary condition since there is no diabetes or damage to 
the islets if hyperglycaemia is prevented by keeping the animal without 
food or by injecting insulin and, on the contrary a diet rich in carbohydrate 
favours the appearance of diabetes (Houssay and Biasotti). Metahypo-
physeal diabetes can be cured during the fi rst weeks and up to 3 months 
after onset, in the cat, ac long as the /3-cells are only damaged and not 
totally destroyed (Lukens and Dohan). This result can be obtained by a 
treatment preventing hyperglycaemia (insulin or phloridzin) or by 
adrenalectomy (Lukens and Dohan). These treatments are no longer 
efficacious once the majority of the /3-cells have been destroyed and 
irreversible atrophy of the islets has occurred. 
The direct toxic action of the anterohypophyseal extract is added to the 
effect of the hyperglycaemia. This extract provokes fatty degeneration 
of the liver, of the small ducts and acini of the pancreas, etc., and death if 
given in sufficient doses. After treatment for 4 days with doses sufficient 
to produce diabetes there are marked lesions in the ß-cells and a con-
siderable decrease of insulin secretion. On the other hand a similar 
hyperglycaemia maintained for 4 days by continuous intravenous injection 
of glucose does not damage these cells nor does it diminish insulin secretion 
in the dog (Houssay, Foglia, Smyth, Rietti and Houssay). The factors 
are therefore equally necessary to damage the islets : hyperglycaemia and 
the direct toxic action of the extract. 
Alloxan diabetes is the prototype of a condition produced by toxic 
destruction of the islet cells. This drug, as soon as it reaches a sufficient 
concentration in the blood, almost immediately destroys the -cells. If 
this destruction is sufficiently widespread, permanent diabetes is the 
consequence ; if a sufficient number of cells resist and recover, diabetes 
disappears in a few days. 
The islet lesions in pancreatic diabetes can be primary or secondary. 
Alloxan has a primary effect. It acts directly on the islets, as is shown by 
the rapidity and selectiveness with which it damages the /3-cells. On the 
other hand, the effects of the anterohypophysis and the thyroids are 
*In the case of thyroid diabetes this same effect is produced by the thyroid treatment. 
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indirect ; fi rst extrapancreatic disturbances occur and later the pancreas 
is affected. Alloxan diabetes is a pancreatic diabetes from the beginning, 
while hypophyseal and thyroid diabetes begin by an extrapancreatic phase 
and only later produce pancreatic diabetes. 
An existing insular lesion can be primary or secondary. In the fi rst 
case the damaging agent acts directly on the ß -cells ; in the second a 
hormonal agent (hyperpituitarism, hyperthyroidism) produces hyper-
glycaemia and lesions in the islets. In time both these types of diabetes 
become identical, both arc due to pancreatic insufficiency and only by 
knowledge of the animal's history can the origin be established. 
An interesting feature in subtotal pancreatectomy in the rat is the fact 
that it does not produce diabetes immediately but only after 2 or 3 months, 
during which the animal has a normal blood sugar. This lapse in the life 
span of a rat is equivalent to several years in human life. Later a pro-
gressive and severe diabetes will inevitably follow. It is possible, therefore. 
that in man manifest diabetes is also preceded by a prediabetic period 
without symptoms. If this does occur there would be great advantages 
in being able to diagnose the condition, and so prevent its progress by 
maintaining or increasing the functional capacity of the degenerating 
pancreas. Studies in this direction might be of extraordinary importance 
for the prevention of diabetes. 
Up to now it has not been possible to provoke an experimental diabetes 
which remains stable at a certain degree of insufficiency. Experimental 
diabetes either progresses towards a cure or, more frequently, gradually 
increases in severity, though sometimes the animals survive for a long 
time. One same agent (anterohypophysis or thyroid) can produce either 
hyperplasia or degenerative lesions of the islet cells, according to which 
animal species is used, the dose given, the amount of pancreas present or 
its anatomical and functional condition. 
In some animals the pancreas is rermarkably resistant to damaging 
agents. By repeated injections of small doses of alloxan it is possible 
to increase the resistance to its toxic effects (Orias). 
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